612 related articles for article (PubMed ID: 31061272)
21. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Postoperative Hepatic Failure after Liver Resection for Hepatocellular Carcinoma: Significance of the Aspartate Aminotransferase-to-Platelet Ratio Index.
Tanaka S; Iimuro Y; Hirano T; Hai S; Suzumura K; Fujimoto J
Hepatogastroenterology; 2014 May; 61(131):755-61. PubMed ID: 26176070
[TBL] [Abstract][Full Text] [Related]
23. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
24. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
[TBL] [Abstract][Full Text] [Related]
25. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes.
Fagenson AM; Gleeson EM; Pitt HA; Lau KN
J Am Coll Surg; 2020 Apr; 230(4):637-645. PubMed ID: 31954813
[TBL] [Abstract][Full Text] [Related]
26. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma.
Ichikawa T; Uenishi T; Takemura S; Oba K; Ogawa M; Kodai S; Shinkawa H; Tanaka H; Yamamoto T; Tanaka S; Yamamoto S; Hai S; Shuto T; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2009; 16(1):42-8. PubMed ID: 19082913
[TBL] [Abstract][Full Text] [Related]
27. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
28. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Xu L; Wu J; Lu W; Yang C; Liu H
Transplant Proc; 2019 Dec; 51(10):3338-3346. PubMed ID: 31732203
[TBL] [Abstract][Full Text] [Related]
29. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
[TBL] [Abstract][Full Text] [Related]
30. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
[TBL] [Abstract][Full Text] [Related]
31. Combined APRI/ALBI score to predict mortality after hepatic resection.
Starlinger P; Ubl DS; Hackl H; Starlinger J; Nagorney DM; Smoot RL; Habermann EB; Cleary SP
BJS Open; 2021 Jan; 5(1):. PubMed ID: 33609383
[TBL] [Abstract][Full Text] [Related]
32. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
[TBL] [Abstract][Full Text] [Related]
33. ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients.
Zhang ZQ; Yang B; Zou H; Xiong L; Miao XY; Wen Y; Zhou JJ
Medicine (Baltimore); 2019 Apr; 98(15):e15168. PubMed ID: 30985698
[TBL] [Abstract][Full Text] [Related]
34. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the LiMAx test vs. the APRI+ALBI score for clinical utility in preoperative risk assessment in patients undergoing liver surgery - A European multicenter study.
Santol J; Ammann M; Reese T; Kern AE; Laferl V; Oldhafer F; Dong Y; Rumpf B; Vali M; Wiemann B; Ortmayr G; Brunner SE; Probst J; Aiad M; Jankoschek AS; Gramberger M; Tschoegl MM; Salem M; Surci N; Thonhauser R; Mazari V; Hoblaj T; Thalhammer S; Schmelzle M; Oldhafer KJ; Gruenberger T; Starlinger P
Eur J Surg Oncol; 2024 Apr; 50(4):108048. PubMed ID: 38471374
[TBL] [Abstract][Full Text] [Related]
36. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
37. Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.
Zou H; Wen Y; Yuan K; Miao XY; Xiong L; Liu KJ
Liver Int; 2018 Mar; 38(3):494-502. PubMed ID: 28685924
[TBL] [Abstract][Full Text] [Related]
38. A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.
Sun LY; Zhu H; Diao YK; Xing H; Liang L; Li J; Zhou YH; Gu WM; Chen TH; Zeng YY; Pawlik TM; Lau WY; Li C; Shen F; Zhang CW; Yang T
Ann Transl Med; 2020 Dec; 8(23):1591. PubMed ID: 33437790
[TBL] [Abstract][Full Text] [Related]
39. Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.
Cheng J; Zhao P; Liu J; Liu X; Wu X
Medicine (Baltimore); 2016 Nov; 95(48):e5486. PubMed ID: 27902606
[TBL] [Abstract][Full Text] [Related]
40. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma.
Mai RY; Ye JZ; Long ZR; Shi XM; Bai T; Chen J; Li LQ; Wu GB; Wu FX
Cancer Manag Res; 2019; 11():1401-1414. PubMed ID: 30863151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
